139 related articles for article (PubMed ID: 34484359)
1. Advanced dose calculation algorithm in superficial brachytherapy - the impact of tissue inhomogeneity on treatment plan dosimetry.
Szlag M; Kellas-Śleczka S; Wojcieszek P; Stankiewicz M; Cholewka A; Pruefer A; Krzysztofiak T; Lelek P; Stąpór-Fudzińska M; Ślosarek K
J Contemp Brachytherapy; 2021 Aug; 13(4):441-446. PubMed ID: 34484359
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric impact of applying a model-based dose calculation algorithm for skin cancer brachytherapy (interventional radiotherapy).
Placidi E; Fionda B; Rosa E; Lancellotta V; Napolitano A; Angeli M; Pastore F; Gambacorta MA; Indovina L; Tagliaferri L; Spirito M
J Contemp Brachytherapy; 2023 Dec; 15(6):448-452. PubMed ID: 38230401
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of a collapsed cone dose calculation algorithm for HDR Ir-192 of APBI treatments.
Terribilini D; Vitzthum V; Volken W; Frei D; Loessl K; van Veelen B; Manser P; Fix MK
Med Phys; 2017 Oct; 44(10):5475-5485. PubMed ID: 28750134
[TBL] [Abstract][Full Text] [Related]
4. [Dosimetric analysis of different optimization algorithms for three-dimensional brachytherapy for gynecologic tumors].
Ling B; Chen L; Zhang J; Cao X; Ye W; Ouyang Y; Chi F; Ding Z
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):773-779. PubMed ID: 38708512
[TBL] [Abstract][Full Text] [Related]
5. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy.
Duque AS; Corradini S; Kamp F; Seidensticker M; Streitparth F; Kurz C; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Fonseca GP; Landry G
Radiat Oncol; 2020 Mar; 15(1):60. PubMed ID: 32151255
[TBL] [Abstract][Full Text] [Related]
6. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
7. Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view.
Scherf C; Licher J; Mletzko C; Trommel M; Tselis N; Chatzikonstantinou G; Diefenhardt M; Rödel C; Köhn J; Ramm U
J Contemp Brachytherapy; 2021 Apr; 13(2):179-187. PubMed ID: 33897792
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Dosimetric Differences in Strut-Adjusted Volume Implant Treatment Plans Calculated With TG-43 Formalism and a Model-Based Dose Calculation Algorithm.
Mazur TR; Hao Y; Garcia-Ramirez J; Altman MB; Li HH; Thomas MA; Zoberi I; Zoberi JE
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1200-1209. PubMed ID: 33662458
[TBL] [Abstract][Full Text] [Related]
9. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a collapsed-cone convolution algorithm for esophagus and surface mold
Eason L; Mason J; Cooper R; Radhakrishna G; Bownes P
Brachytherapy; 2021; 20(2):393-400. PubMed ID: 33071170
[TBL] [Abstract][Full Text] [Related]
11. Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer.
Abe K; Kadoya N; Sato S; Hashimoto S; Nakajima Y; Miyasaka Y; Ito K; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Jingu K
J Radiat Res; 2018 Mar; 59(2):198-206. PubMed ID: 29378024
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer.
Shahbazian H; Birgani MJT; Bagheri A; Arvandi S; Razmjoo S; Ghadamgahi P; Bakhali R; Feli M
J Contemp Brachytherapy; 2020 Apr; 12(2):201-206. PubMed ID: 32395146
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of surface mould HDR brachytherapy with VMAT.
Boman EL; Paterson DB; Pearson S; Naidoo N; Johnson C
J Med Radiat Sci; 2018 Dec; 65(4):311-318. PubMed ID: 30105776
[TBL] [Abstract][Full Text] [Related]
16. Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa.
Murakami N; Ueno T; Yatsuoka W; Okamoto H; Tselis N; Masui K; Yoshida K; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
J Contemp Brachytherapy; 2018 Oct; 10(5):486-491. PubMed ID: 30479628
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
18. Validation of the collapsed cone algorithm for HDR liver brachytherapy against Monte Carlo simulations.
Duque AS; van Wagenberg T; Seidensticker M; Streitparth F; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Paiva Fonseca G; Corradini S; Landry G
Brachytherapy; 2021; 20(4):936-947. PubMed ID: 34001415
[TBL] [Abstract][Full Text] [Related]
19. High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes.
Anderson JW; Xia J; Flynn RT; Modrick JM; Bhatia SK; Jacobson GM; Kim Y
J Contemp Brachytherapy; 2013 Jun; 5(2):101-9. PubMed ID: 23878555
[TBL] [Abstract][Full Text] [Related]
20. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
